GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (STU:LSI) » Definitions » ROC (Joel Greenblatt) %

CK Life Sciences International Holdings (STU:LSI) ROC (Joel Greenblatt) % : 9.16% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. CK Life Sciences International Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 9.16%.

The historical rank and industry rank for CK Life Sciences International Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

STU:LSI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 6.12   Med: 12.24   Max: 19.03
Current: 9.43

During the past 13 years, CK Life Sciences International Holdings's highest ROC (Joel Greenblatt) % was 19.03%. The lowest was 6.12%. And the median was 12.24%.

STU:LSI's ROC (Joel Greenblatt) % is ranked better than
85.47% of 1466 companies
in the Biotechnology industry
Industry Median: -332.005 vs STU:LSI: 9.43

CK Life Sciences International Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -9.10% per year.


CK Life Sciences International Holdings ROC (Joel Greenblatt) % Historical Data

The historical data trend for CK Life Sciences International Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings ROC (Joel Greenblatt) % Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.84 5.88 8.24 9.23 9.41

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.98 7.83 10.29 9.44 9.16

Competitive Comparison of CK Life Sciences International Holdings's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, CK Life Sciences International Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's ROC (Joel Greenblatt) % falls into.



CK Life Sciences International Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(124.236 + 152.562 + 1.632) - (85.836 + 0 + 0)
=192.594

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(104.934 + 141.433 + 19.49) - (54.26 + 0 + 48.924)
=162.673

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of CK Life Sciences International Holdings for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=45.198/( ( (309.122 + max(192.594, 0)) + (322.631 + max(162.673, 0)) )/ 2 )
=45.198/( ( 501.716 + 485.304 )/ 2 )
=45.198/493.51
=9.16 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings  (STU:LSI) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


CK Life Sciences International Holdings ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (STU:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (STU:LSI) Headlines